Login to MyKarger

New to MyKarger? Click here to sign up.

Login with Facebook

Forgot Password? Reset your password

Authors, Editors, Reviewers

For Manuscript Submission, Check or Review Login please go to Submission Websites List.

Submission Websites List

Institutional Login (Shibboleth)

For the academic login, please select your country in the dropdown list. You will be redirected to verify your credentials.

Table of Contents
Vol. 23, Suppl. 1, 2010
Issue release date: September 2010
Section title: Paper
Free Access
Skin Pharmacol Physiol 2010;23(suppl 1):45–51
(DOI:10.1159/000318267)

Clinical Use of Polihexanide on Acute and Chronic Wounds for Antisepsis and Decontamination

Eberlein T.a · Assadian O.b
aDermatologist/Allergologist, Palma, Spain; bInstitute of Hygiene and Environmental Medicine, Ernst Moritz Arndt University Greifswald, Greifswald, Germany
email Corresponding Author

Ojan Assadian, MD, DTMH

Institute of Hygiene and Environmental Medicine

Ernst Moritz Arndt University Greifswald, Walther Rathenau Strasse 49a

DE–17489 Greifswald (Germany)

Tel. +49 3834 515 540, Fax +49 3834 515 541, E-Mail assadian@uni-greifswald.de


References

  1. Pringle J: Observations on the Diseases of the Army, ed 4 revised. London, Millar, Wilson, Durham, Payne, 1764.
  2. Lister J: Amputation, anaesthetics; in Holmes T (ed): A System of Surgery, Theoretical and Practical. London, Robson, Levey, and Franklin, 1860, vol 3: Operative Surgery.
  3. Lister J: On the antiseptic principle on the practice of surgery. Lancet 1867;90:353–356.
    External Resources
  4. Kocher T: Die antiseptische Wundbehandlung mit schwachen Chlorzinklösungen in der Berner Klinik; in Volksmanjn R (ed): Sammlung klinischer Vorträge. Leipzig, Breitkopf und Härtel, 1881.
  5. Carrel A, Lecomte Du Noüy P, Carrel A: Cicatrization of wounds. 9. Influence on the healing of wounds of variations in the osmotic tension of the dressing. J Exp Med 1917;26:279–295.
  6. Lister J: An address on the present position of antiseptic surgery. BMJ 1890;1546:377–379.
    External Resources
  7. Gillespie WA: Chemical disinfection in the prevention of infection in hospital. J Clin Pathol 1961;14:26–31.
  8. Willenegger H, Roth B, Ochsner P: The return of local antiseptics in surgery. Injury 1995;26:28–33.
    External Resources
  9. Davies A, Field BS: Action of biguanides, phenols and detergents on Escherichia coli and its spheroplasts. J Appl Bact 1969;23:233–243.
  10. Ikeda T, Tazuke S, Watanabe M: Interaction of biologically active molecules with phospholipid membranes. Fluorescence depolarisation studies on the effect of polymeric biocide bearing biguanides in the main chain. Biochim Biophys Acta 1983;735:380–386.
  11. Werner HP: Microbicidal effectiveness of selected antiseptics. Hyg Med 1992;17:51–59.
  12. Kramer A, Adrian V, Werner HP: Mikrobizidie und Gewebeverträglichkeit des Antiinfektivums Lavasept® mit Schlussfolgerungen für die Indikationbreite; in Ganzer D, Kramer A, Mayer G (eds): Prophylaxe und Therapie von Infektionen in der Orthopädie. Wiesbaden, mhp, 1997, pp 11–26.
  13. Schmit-Neuerburg K, Bettag C, Schlickewei W, Fabry W, Hanke J, Renzig-Köhler K, Hirche H, Kock HJ: Wirksamkeit eines neuartigen Antisepticum in der Behandlung kontaminierter Weichteilwunden. Chirurg 2001;72:61–71.
  14. Fabry W, Trampenau C, Bettag C, Handschin AE, Lettgen B, Huber FX, Hillmeier J, Kock AJ: Bacteria decontamination of surgical wounds with Lavasept®. Int J Hyg Environ Health 2006;209:567–573.
  15. Roth B, Assadian O, Wurmitzer F, Kramer A: Surgical site infections after primary antiseptic cleansing of dirty-contaminated wounds by polihexanide, PVP iodine resp. hydrogen peroxide. GMS Krankenhaushyg Interdiszip 2007;2:Doc58(20071228).
  16. Müller G, Kramer A: Biocompatibility index of antiseptic agents by parallel assessment of antimicrobial activity and cellular cytotoxicity. J Antimicrob Chemother 2008;61:1281–1287.
    External Resources
  17. Disch AC, Matziolis G, Perka C: Two-stage operative strategy without local antibiotic treatment for infected hip arthroplasty: clinical and radiological outcome. Arch Orthop Trauma Surg 2007;127:691–697.
    External Resources
  18. Schmidtchen A, Davoudi M, Andersson E: Potent antibacterial effects of polyhexamethylene biguanide on common chronic ulcer-derived bacteria. Annu Conf EWMA, Pisa, 2003.
  19. Kramer A, Roth B: Polihexanid; in Kramer A, Assadian O (eds): Wallhäussers Praxis der Sterilisation, Desinfektion, Antiseptik und Konservierung. Stuttgart, Thieme, 2008, pp 789–793.
  20. Rosin M, Welk A, Kocher T, Majic-Todt A, Kramer A, Pitten FA: The effect of a polyhexamethylene biguanide mouthrinse compared to an essential oil rinse and a chlorhexidine rinse on bacterial counts and 4-day plaque regrowth. J Clin Periodontol 2002;29:392–399.
  21. Wiegand C, Abel M, Kramer A, Müller G, Ruth P, Hipler UC: Viability and proliferation of fibroblasts, keratinocytes and HaCaT-cells influenced by polihexanide. EWMA J;7:109.
  22. Wiegand C, Abel M, Ruth P, Hipler U: Protective effect of polihexanide on HaCaT keratinocytes in co-culture with Staphylococcus aureus. EWMA J 2008;8:178.
  23. Kramer A, Roth B, Muller G, Rudolph P, Klocker N: Influence of the antiseptic agents polihexanide and octenidine on FL-cells and on healing of experimental superficial aseptic wounds in piglets. A double-blind, randomised, stratified, controlled, parallel-group study. Skin Pharmacol Physiol 2004;17:141–146.
  24. Daeschlein G, Assadian O, Bruck JC, Meinl C, Kramer A, Koch S: Feasibility and clinical applicability of polihexanide for treatment of second-degree burn wounds. Skin Pharmacol Physiol 2007;20:292–296.
  25. Bolton L, Oleniacz W, Constantine B, Kelliher BO, Jensen D, Means B, Rovee D: Repair and antibacterial effects of topical antiseptic agents in vivo; in Maibach Hl, Lowe NJ (eds): Models in Dermatology. Basel, Karger, 1985, pp 145–158.
  26. Kallenberger A, Kallenberger C, Willenegger H: Experimentelle Untersuchungen zur Gewebeverträglichkeit von Antiseptika. Hyg Med 1991;16:383–395.
  27. Andriessen A, Eberlein T: Assessment of a wound cleansing solution in the treatment of problem wounds. Wounds 2008;20:171–175.
  28. Ikeda T, Tazuke S, Watanabe M: Interaction of biologically active molecules with phospholipid membranes. 1. Fluorescence depolarization studies on the effect of polymeric biocide bearing biguanide groups in the main chain. Biochim Biophys Acta 1983;735:380–386.
  29. Müller G, Kramer A: Biocompatibility index of antiseptic agents by parallel assessment of antimicrobial activity and cellular cytotoxicity. J Antimicrob Chemother 2008;61:1281–1287.
    External Resources
  30. Assadian O, Kramer A: Antisepsis; in Kramer A, Assadian O (eds): Wallhäussers Praxis der Sterilisation, Desinfektion, Antiseptik und Konservierung. Stuttgart, Thieme, 2008.
  31. Gilbert P, Moore LE: Cationic antiseptics: diversity of action under a common epithet. J Appl Microbiol 2005;99:703–715.
  32. Pietsch M, Kraft B: Antimikrobielle Wirksamkeit ausgewählter Substanzen für die Wasserdesinfektion in Dentaleinheiten mit Biofilm. Aseptica 2006;12:3.
  33. Harbs N, Siebert J: In vitro efficacy of octenidine and polihexanide against biofilms composed of Pseudomonas aeruginosa. GMS Krankenhaushyg Interdiszip 2007;2:Doc45(20071228).
  34. Seipp HM, Hofmann S, Hack A, Skowronsky A, Hauri A: Wirksamkeit verschiedener Wundspüllösungen gegenüber Biofilmen. ZfW 2005;10:160–164.
  35. Daeschlein G, Assadian O, Bruck JC, Meinl C, Kramer A, Koch S: Feasibility and clinical applicability of polihexanide for treatment of second-degree burn wounds. Skin Pharmacol Physiol 2007;20:292–296.
  36. Körber A, Seipp H-M, Hofmann S: Efficacy of different wound dressings on artificial plaques of fibrin. EWMA J 2008;8:261.
  37. Kaehn K, Eberlein T: Polyhexanide (PHMB) and betaine in wound care management. EWMA J 2008;8:13–17.
  38. Mulder GD, Cavorsi JP, Lee DK: Feature: Polyhexamethylene biguanide (PHMB): an addendum to current topical antimicrobials. Wounds 2007;19:173–182.
  39. Bruckner M, Schwarz C, Otto F, Heillinger J, Wild T: Evaluation of cellulose and polyhexamethylene biguanide (Suprasorb® X+PHMB) in therapy of infected wounds. EWMA J 2008;8:54.
  40. Mosti G, Mattaliano V: First Italian experience with a hydrobalanced cellulose-based wound dressing on hospital-patients with critically-colonized or locally infected chronic wounds. Poster. EWMA J 2008;8:168.
  41. Mosti G, Mattaliano V: Successful therapy of critically-colonised or locally infected wounds with a new hydrobalanced cellulose-based wound dressing with polihexanide on out-patients. EWMA J 2008;8:169.
  42. Wiegand C, Abel M, Ruth P, Hipler UC: Polihexanide inhibits the formation of ROS/RNS in vitro. EWMA J 2008;8:178.
  43. Schnuch A, Geier J, Uter W, Basketter DA, Jowsey IR: The biocide polyhexamethylene biguanide remains an uncommon contact allergen. Contact Dermatitis 2007;56:235–239.
  44. Schnuch A, Geier J, Brasch J, Fuchs T, Pirker C, Schulze-Dirks A, Basketter DA: Polyhexamethylenebiguanide: a relevant contact allergen? Contact Dermatitis 2000;42:302–303.
  45. Freise J, Kohaus S, Korber A, Hillen U, Kroger K, Grabbe S, Dissemond J: Contact sensitization in patients with chronic wounds: results of a prospective investigation. J Eur Acad Dermatol Venereol 2008;22:1203–1207.
  46. Krautheim AB, Jermann TH, Bircher AJ: Chlorhexidine anaphylaxis: case report and review of the literature. Contact Dermatitis 2004;50:113–116.
  47. Deutscher Arzneimittel-Codex DAC/Neues Rezeptur-Formularium NRF. Eschborn, Govi, 2008.
  48. Wilhelms T, Schulze D, Alupei IC, Rohrer C, Abel M, Wiegand C, Hipler UC: Release of polyhexamethylene biguanidine hydrochloride (PHMB) from a hydrobalanced cellulose wound dressing with PHMB. EWMA J 2007;7:113.
  49. Werner H, Kramer A: Mikrobiologische Anforderungen an lokale Antiinfektiva unter spezieller Berücksichtigung der antiinfektiven Wundbehandlung; in Kramer A, Wendt M, Werner H-P (eds): Möglichkeiten und Perspektiven der klinischen Antiseptik. Wiesbaden, mhp, 1995, pp 26–30.
  50. European Wound Management Association (EWMA): Position Document: Identifying Criteria for Wound Infection. London, MEP Ltd, 2005, pp 1–17.
  51. Dissemond J, Gerber V, Kramer A, Riepe G, Strohal R, Vasel-Biergans A, Eberlein T: Practice-oriented expert recommendation for the treatment of critically colonised and locally infected wounds using polihexanide. ZfW 2009;14:20–26.
  52. Dissemond J, Gerber V, Kramer A, Riepe G, Strohal R, Vasel-Biergans A, Eberlein T: A practice-orientated recommendation for treatment of critically colonized and locally infected wounds using polihexanide. J Wound Tech 2010;7:27–33.
  53. Kammerlander G, Andriessen A, Asmussen P D, Brunner U, Eberlein T: Role of the wet-to-dry phase of cleansing in preparing the chronic wound bed for dressing application. J Wound Care 2005;14:349–352.